II FTC – Advanced Therapies and Orphan Drugs
The II Foresight Training Course was organised in collaboration with the Italian Society of Regulatory Activites (SIAR), Consortium for Biological and Pharmacological Evaluations (CVBF), the Task-force in Europe for Drug Development for the Young (TEDDY), the Master in Regulatory Sciences “Gianni Benzi” (University of Pavia), the European Association for Bioindustries (EUROPABIO) and the Middle European Association (MEGRA).
The Course dealt with the newest fields developed in the last years and particularly Advanced Therapies, Orphan Drugs and Paediatric Medicines.
The II FTC represented an opportunity to personally meet some of the members of the EMA, Committee for Advanced Therapies (CAT), Committee for Orphan Medicinal Product (COMP) and Paediatric Committee (PDCO).
Download the agenda here!